Doyle ME - Search Results

1

Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-κB signaling.

Kim Y, Gautam S, Aseer KR, Kim J, Chandrasekaran P, Mazucanti CH, Ghosh P, O'Connell JF, Doyle ME, Appleton A, Lehrmann E, Liu QR, Egan JM. Kim Y, et al. Among authors: doyle me. Cell Death Dis. 2020 Dec 9;11(12):1044. doi: 10.1038/s41419-020-03261-8. Cell Death Dis. 2020. PMID: 33298885 Free PMC article.

2

Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells.

Wang X, Cahill CM, Piñeyro MA, Zhou J, Doyle ME, Egan JM. Wang X, et al. Among authors: doyle me. Endocrinology. 1999 Oct;140(10):4904-7. doi: 10.1210/endo.140.10.7158. Endocrinology. 1999. PMID: 10499550

3

Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats.

Szayna M, Doyle ME, Betkey JA, Holloway HW, Spencer RG, Greig NH, Egan JM. Szayna M, et al. Among authors: doyle me. Endocrinology. 2000 Jun;141(6):1936-41. doi: 10.1210/endo.141.6.7490. Endocrinology. 2000. PMID: 10830274

4

Glucagon-like peptide-1.

Doyle ME, Egan JM. Doyle ME, et al. Recent Prog Horm Res. 2001;56:377-99. doi: 10.1210/rp.56.1.377. Recent Prog Horm Res. 2001. PMID: 11237222 Review.

5

Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.

Wang X, Zhou J, Doyle ME, Egan JM. Wang X, et al. Among authors: doyle me. Endocrinology. 2001 May;142(5):1820-7. doi: 10.1210/endo.142.5.8128. Endocrinology. 2001. PMID: 11316746

6

Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent.

Doyle ME, Greig NH, Holloway HW, Betkey JA, Bernier M, Egan JM. Doyle ME, et al. Endocrinology. 2001 Oct;142(10):4462-8. doi: 10.1210/endo.142.10.8410. Endocrinology. 2001. PMID: 11564711

7

Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors.

Zhou J, Pineyro MA, Wang X, Doyle ME, Egan JM. Zhou J, et al. Among authors: doyle me. J Cell Physiol. 2002 Sep;192(3):304-14. doi: 10.1002/jcp.10143. J Cell Physiol. 2002. PMID: 12124776

8

Pharmacological agents that directly modulate insulin secretion.

Doyle ME, Egan JM. Doyle ME, et al. Pharmacol Rev. 2003 Mar;55(1):105-31. doi: 10.1124/pr.55.1.7. Pharmacol Rev. 2003. PMID: 12615955 Review.

9

The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity.

Doyle ME, Theodorakis MJ, Holloway HW, Bernier M, Greig NH, Egan JM. Doyle ME, et al. Regul Pept. 2003 Jul 15;114(2-3):153-8. doi: 10.1016/s0167-0115(03)00120-4. Regul Pept. 2003. PMID: 12832104 Free PMC article.

10

In vivo biological activity of exendin (1-30).

Doyle ME, McConville P, Theodorakis MJ, Goetschkes MM, Bernier M, Spencer RG, Holloway HW, Greig NH, Egan JM. Doyle ME, et al. Endocrine. 2005 Jun;27(1):1-9. doi: 10.1385/ENDO:27:1:001. Endocrine. 2005. PMID: 16077164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page